Medicare Pilot Program Offers GLP-1 Discounts, Excludes Certain Patients

Why it matters locally: While the pilot program is national, its exclusion of certain patients with severe illnesses could disproportionately affect California's large senior population, many of whom rely on Medicare for their healthcare needs.

---

Medicare has introduced a pilot program aimed at streamlining access to GLP-1 medications. Under this initiative, some seniors pay $50 per month for these drugs. However, the program's structure means that many individuals with severe illnesses do not qualify for this reduced rate. Jeff La Marca, for example, received a prescription for the weight-loss drug Zepbound in January. He faced a monthly cost of $750 for the medication.